• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dominari Securities LLC Continues Expansion of Its Capital Market Group with Senior Hires

    4/17/24 8:30:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $DOMH alert in real time by email

    Adds Capital Markets Expert and Best-Selling Author, Steve Kann and Strategic and Financial Advisory Veteran, Andre Peschong, as Managing Directors

    NEW YORK, NY / ACCESSWIRE / April 17, 2024 / Dominari Holdings Inc. (NASDAQ:DOMH) (the "Company") today noted that its wholly-owned subsidiary, Dominari Securities LLC, announced that it has further expanded its practice with the addition of Steve Kann and Andre Peschong as Managing Directors.

    Mr. Kyle Wool, CEO of Dominari Securities LLC, commented, "The breadth and depth of experience that Steve and Andre bring to the team will be extremely valuable in helping us to realize our strategic vision of developing Dominari into a full-serve, diversified financial services firm. They have each served in the Boardroom and held senior positions with multiple investment banks advising the C-Suite on numerous financing and strategic transactions. With a rich and detailed understanding of the capital markets and a vast network of industry relationships, I am confident they will be instrumental in taking Dominari to the next level. We are pleased to welcome Steve and Andre to the team."

    Steve Kann

    Mr. Kann has more than 30 years of experience in corporate finance, buy and sell-side equity research, operations, marketing, consulting and has been a founder, advisor, agent, banker and investor in dozens of companies during his career. He has also served as a mentor for startup accelerators, AccelerateDC and Startup Grind NY.

    Steve is a recognized expert in microcap stocks and has been interviewed by the Los Angeles Times, the Washington Times, the Washington Business Journal, Equities.com and many business podcasts. He has moderated and participated in investment panels at major conferences, including CES and CEA Innovate!

    He was the co-founder and Editor of BullMarket.com's Bull Market Microcap Review, a top-performing subscription investment newsletter that provided commentary and analysis on under-followed microcap stocks. Subsequently, Steve served as a microcap equity analyst for Think20/20, an independent equities research firm. He is also the author of the Amazon #1 Best Seller, Microcap Magic: Why the biggest returns are in the stocks you've never heard of, published in 2015.

    Mr. Kann has provided clients with top-tier advisory work, and some of his joint-venture partners have included, America Online, Metrocall (now USA Mobility), Ralph Edwards Productions (creator of classic TV shows Truth or Consequences and This Is Your Life) and many others.

    Steve loves the entertainment business and served as Executive Producer of the feature film, Moving Target, in 1994 and advisor on the feature film, Checkout, in 2002. He is also part of a songwriting team with Justin Sheehy. The two have a catalog of 50 songs under their Jamsmack label. You can listen to some of the songs on: broadjam.com/jamsmack.

    Mr. Kann holds a B.A. from George Mason University in Virginia, which he attended on a baseball scholarship.

    Andre Peschong

    Mr. Peschong has more than 25 years of corporate finance, investment banking, senior management, business development and capital markets experience. He is currently the Chairman of the Board of Impossible Kicks, one of the largest brick and mortar sneaker resellers in the United States. He remains an active partner in Ocean Street Partners, a merchant banking and corporate advisory firm.

    Prior to Ocean Street, he co-founded and served as managing partner of Bridgewater Capital Corporation, a corporate strategy and advisory firm focused on, capital formation and comprehensive business and revenue development for public and private companies across a range of industries from mobile and security to eCommerce, life sciences, healthcare and consumer products and services.

    Earlier in his career, Mr. Peschong co-managed three investment funds, served as CEO of a consumer products company and was Chief Strategy Officer and a Board member of an adtech company that was subsequently sold to a larger player within the industry. He has authored and been quoted in articles on angel investing and the economy that have been published in Forbes, Businessweek, the New York Times and on Seeking Alpha.

    For additional information about Dominari Holdings Inc., please visit: https://www.dominariholdings.com/

    Dominari Securities LLC's Mission Statement:

    Dominari Securities LLC, a principal subsidiary of Dominari Holdings Inc., is a dynamic, forward-thinking financial services company that seeks to create wealth for all stakeholders by capitalizing on emerging trends in the financial services sector and identifying early-stage future opportunities that are expected to generate a high rate of return for investors.

    Securities Brokerage and Registered Investment Adviser Services are offered through Dominari Securities LLC, a Member of FINRA, MSRB and SIPC. Securities brokerage, investment adviser and other non-bank deposit investments are not FDIC insured and may lose some or all of the principal invested. You can check the background of Dominari Securities and its registered investment professionals and review its SEC Form CRS on FINRA's BrokerCheck site at https://brokercheck.finra.org. Information for Dominari Securities LLC and its registered investment professionals as well as its SEC Form CRS may also be found on FINRA's BrokerCheck site.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company's filings with the SEC, which include but are not limited to the Risk Factors set forth in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2022 relating to its business. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.

    Contacts:

    Dominari Holdings Inc.

    https://www.dominariholdings.com/
    Investor Relations

    Hayden IR

    Brett Maas, Managing Partner
    Phone: (646) 536-7331
    Email: [email protected]
    www.haydenir.com

    SOURCE: Dominari Holdings Inc.



    View the original press release on accesswire.com

    Get the next $DOMH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DOMH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DOMH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Ledwick Tim S

    4 - Dominari Holdings Inc. (0000012239) (Issuer)

    3/25/26 8:10:56 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Hayes Anthony

    4 - Dominari Holdings Inc. (0000012239) (Issuer)

    3/24/26 9:23:32 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Haug Kyle

    4 - Dominari Holdings Inc. (0000012239) (Issuer)

    3/24/26 9:23:14 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOMH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Dominari Releases Letter to Shareholders and Clients

    NEW YORK, March 16, 2026 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) today released the following letter to clients and shareholders: Dear Dominari Clients and Shareholders,As reported in certain media outlets, Dominari Securities LLC ("Dominari" or the "Company") recently received a letter dated March 8, 2026 from the U.S. House Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party requesting information regarding the underwriting of initial public offerings (IPOs) by Chinese companies. Dominari takes this inquiry serio

    3/16/26 8:00:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    New American Drone and Defense Company to be Created Through Merger of Powerus and Aureus Greenway Holdings

    -  Notable Investors of Combined Company Include American Venture Partners Eric Trump and Donald Trump Jr.; Additional Support from Leading U.S. Drone Manufacturer Unusual Machines ("UMAC") and a Strategic $50 Million Investment -  Combination Advances American Domination of Drone Industry and Autonomous Systems Innovation WEST PALM BEACH, Fla., March 09, 2026 (GLOBE NEWSWIRE) -- Aureus Greenway Holdings Inc. (NASDAQ:AGH) today announced that AGH and Autonomous Power Corporation, doing business as Powerus (www.Power.us), a company co-founded by former U.S. Army Special Operations veterans that builds and scales autonomous drone systems for military and commercial use in high-risk environ

    3/9/26 8:00:00 AM ET
    $AGH
    $DOMH
    $UMAC
    Hotels/Resorts
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Holdings Issues Letter to Shareholders

    NEW YORK, Jan. 28, 2026 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) ("Dominari" or the "Company") today issued the following letter to shareholders: I am pleased to report that 2025 was a transformative and highly successful year for Dominari. Through disciplined execution, expanded distribution capabilities, and a focus on high-growth opportunities across both public and private markets, we delivered strong financial performance and created substantive shareholder value. Shareholder Value Creation As we began 2025, the Company's stock price was just over $1.00. When

    1/28/26 8:30:00 AM ET
    $DOMH
    $TZUP
    $UMAC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    EDP Services
    Technology

    $DOMH
    SEC Filings

    View All

    Dominari Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Dominari Holdings Inc. (0000012239) (Filer)

    3/31/26 9:20:25 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Dominari Holdings Inc.

    10-K - Dominari Holdings Inc. (0000012239) (Filer)

    3/31/26 8:12:50 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Dominari Holdings Inc. (0000012239) (Filer)

    3/23/26 4:30:08 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOMH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: CEO Hayes Anthony bought $89,054 worth of shares (23,000 units at $3.87), increasing direct ownership by 1% to 1,750,873 units (SEC Form 4)

    4/A - Dominari Holdings Inc. (0000012239) (Issuer)

    12/10/25 9:22:01 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: President Wool Kyle Michael bought $96,798 worth of shares (25,000 units at $3.87), increasing direct ownership by 2% to 1,211,828 units (SEC Form 4)

    4/A - Dominari Holdings Inc. (0000012239) (Issuer)

    12/10/25 9:20:35 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President Wool Kyle Michael decreased direct ownership by 1% to 2,453,817 units (SEC Form 4)

    4 - Dominari Holdings Inc. (0000012239) (Issuer)

    12/10/25 7:54:17 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOMH
    Leadership Updates

    Live Leadership Updates

    View All

    Dominari Expands Strategic Leadership with Appointment of Ambassador Jamie McCourt to Advisory Board

    Dominari Withdraws $2 Billion Shelf Registration NEW YORK, Dec. 8, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) today announced a major enhancement to its strategic leadership with the appointment of Ambassador Jamie McCourt to the Advisory Board of Dominari Securities. Separately, the company has formally withdrawn its previously filed $2 billion shelf registration statement, reflecting confidence in its financial position and growth outlook. Globally recognized diplomat, executive and entrepreneur Ambassador Jamie McCourt Joins Advisory Board Ambassador McCourt

    12/8/25 8:30:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Securities Receives Approval as a Limited Underwriting Member of the New York Stock Exchange

    Enables direct participation in underwriting activities conducted through NYSE and NYSEAmerican platforms NEW YORK, Oct. 9, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) ("Dominari" or the "Company") today announced that its wholly owned subsidiary, Dominari Securities LLC, has been approved as a Limited Underwriting member of the New York Stock Exchange and NYSE American Equities (the "Exchanges") effective October 8, 2025. This approval marks an important regulatory milestone for Dominari Securities as it continues to expand its capabilities within U.S. capital m

    10/9/25 8:00:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Securities Appoints Communications and Growth Strategist Brian Parsley to Board

    Accomplished entrepreneur and global speaker to strengthen firm's marketing, investor engagement and strategic communications to help drive growth NEW YORK, Sept. 10, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH), today announced the appointment of Brian Parsley to its Board of Directors. Parsley, an accomplished entrepreneur, behavioral analyst and internationally recognized speaker, will support the firm's growth by enhancing its marketing, investor outreach and overall communications strategy. Mr. Parsley has more than 30 years of experience in entrepreneurship,

    9/10/25 8:30:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOMH
    Financials

    Live finance-specific insights

    View All

    Dominari Holdings Issues Letter to Shareholders

    NEW YORK, Jan. 28, 2026 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) ("Dominari" or the "Company") today issued the following letter to shareholders: I am pleased to report that 2025 was a transformative and highly successful year for Dominari. Through disciplined execution, expanded distribution capabilities, and a focus on high-growth opportunities across both public and private markets, we delivered strong financial performance and created substantive shareholder value. Shareholder Value Creation As we began 2025, the Company's stock price was just over $1.00. When

    1/28/26 8:30:00 AM ET
    $DOMH
    $TZUP
    $UMAC
    Biotechnology: Pharmaceutical Preparations
    Health Care
    EDP Services
    Technology

    Dominari Holdings Announces Change of Record Date and Payment Date for $10 Million Cash Dividend

    NEW YORK, Dec. 12, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) is pleased to announce that, following its press release issued on December 11, 2025, the board of directors has updated the record date and payment date for the previously announced special cash dividend of approximately $10 million, or approximately $0.44 per share. The dividend is now payable on or about January 26, 2026, to DOMH's common stock shareholders and certain DOMH warrant holders (on an as-exercised basis) of record as of the close of business on January 5, 2026. For additional informatio

    12/12/25 5:45:00 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dominari Holdings Announces $10 Million Cash Dividend

    NEW YORK, Dec. 11, 2025 /PRNewswire/ -- Dominari Holdings Inc. (NASDAQ:DOMH) is pleased to announce that its board of directors has authorized a special cash dividend of, in the aggregate, approximately $10 million, or approximately $0.44 per share.  The dividend is payable on or about January 23, 2026, to DOMH's common stock shareholders and certain DOMH warrant holders (on an as-exercised basis) of record as of the close of business on December 31, 2025. For additional information about Dominari Holdings Inc., please visit: https://www.dominariholdings.com/ About Dominari Ho

    12/11/25 7:00:00 AM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DOMH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Dominari Holdings Inc.

    SC 13D/A - Dominari Holdings Inc. (0000012239) (Subject)

    6/13/24 8:56:04 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Dominari Holdings Inc.

    SC 13D/A - Dominari Holdings Inc. (0000012239) (Subject)

    6/13/24 4:32:07 PM ET
    $DOMH
    Biotechnology: Pharmaceutical Preparations
    Health Care